Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of oral LGH447 with or without midostaurin in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndrome
NL-OMON44931Active, not recruiting
- Sponsor
- Novartis
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of PIM447 and midostaurin, sponsored by Novartis. Started Mar 2014; status: active, not recruiting.
02
Drugs
PIM447midostaurin
Beyond the preview
Go deeper on NL-OMON44931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44931.